|
1
|
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
|
Nat Genet
|
1997
|
6.83
|
|
2
|
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer.
|
J Clin Oncol
|
1992
|
3.00
|
|
3
|
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.
|
J Med Genet
|
2008
|
2.79
|
|
4
|
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
|
Hum Mutat
|
1998
|
2.64
|
|
5
|
Hereditary papillary renal cell carcinoma.
|
J Urol
|
1994
|
1.87
|
|
6
|
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.
|
J Med Genet
|
2005
|
1.85
|
|
7
|
Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.
|
Cancer Res
|
1998
|
1.66
|
|
8
|
Hereditary papillary renal cell carcinoma: clinical studies in 10 families.
|
J Urol
|
1995
|
1.53
|
|
9
|
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
|
Am J Pathol
|
1999
|
1.52
|
|
10
|
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels.
|
Ann Surg Oncol
|
2001
|
1.49
|
|
11
|
Dynamic contrast-enhanced magnetic resonance imaging in oncology.
|
Top Magn Reson Imaging
|
2001
|
1.38
|
|
12
|
Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia.
|
Am J Med Genet
|
1998
|
1.21
|
|
13
|
Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3.
|
Genomics
|
1990
|
1.18
|
|
14
|
Screening for von Hippel-Lindau disease by DNA polymorphism analysis.
|
JAMA
|
1992
|
1.14
|
|
15
|
The urological manifestations of chronic granulomatous disease.
|
J Urol
|
1992
|
1.13
|
|
16
|
Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings.
|
Surgery
|
1989
|
1.04
|
|
17
|
Familial renal oncocytoma: clinicopathological study of 5 families.
|
J Urol
|
1998
|
1.00
|
|
18
|
Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus.
|
Hum Genet
|
1991
|
0.98
|
|
19
|
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar).
|
Cancer
|
2001
|
0.98
|
|
20
|
Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
|
Clin Radiol
|
2008
|
0.97
|
|
21
|
Imaging of urea using chemical exchange-dependent saturation transfer at 1.5T.
|
J Magn Reson Imaging
|
2000
|
0.97
|
|
22
|
Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833.
|
J Clin Oncol
|
2001
|
0.91
|
|
23
|
Novel gastrointestinal tract manifestations in juvenile dermatomyositis.
|
J Pediatr
|
1999
|
0.84
|
|
24
|
Impaired renal function in progressive multiple sclerosis.
|
Neurology
|
2002
|
0.83
|
|
25
|
Improving PET spatial resolution and detectability for prostate cancer imaging.
|
Phys Med Biol
|
2014
|
0.83
|
|
26
|
Monitoring responses to antiangiogenic agents using noninvasive imaging tests.
|
Cancer J Sci Am
|
2000
|
0.80
|
|
27
|
Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium.
|
Am J Transplant
|
2015
|
0.80
|
|
28
|
Improving image contrast using principal component analysis for subsequent image segmentation.
|
J Comput Assist Tomogr
|
2001
|
0.79
|
|
29
|
Three-dimensional changes in the upper airway during neuromuscular stimulation of laryngeal muscles.
|
Artif Organs
|
1999
|
0.76
|